Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
John Kratz, MD, Professor, Department of Surgery, Medical University of South Carolina, discusses blood glucose monitoring in the peri-operative period in heart surgery. References and Resources Hovorka R,…
John Kratz, MD, Professor, Department of Surgery, Medical University of South Carolina, discusses infections in pacemakers. References and Resources Cawley PJ, Ravindrin BK, Poole JE. Not the usual…
John S. Ikonomidis, MD, PhD, Associate Professor, Cardiothoracic Surgery, Medical University of South Carolina, discusses the risk of mortality associated with aortic valve replacement. References and Resources Dewey…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses volumetric arc therapy. References and Resources…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses the licensing and education for the naturopathic profession. References and Resources Parkman CA. A look at…
James B. McGuire, DPM, PT, Director, Leonard Abrams Center for Advanced Wound Healing of the Foot and Ankle Institute, Department of Podiatric Medicine and Orthopedics, Temple University School…
Victor Kim, MD, Assistant Professor of Medicine, Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses the effects of statins in patients with COPD using the…
A recent study shows that malignant high-grade PINs have a greater expression of PTOV1 (prostate tumor overexpressed-1) compared with benign lesions, and as expression of PTOV1 decreased, so…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses the risks of using both complimentary medicine and conventional medicine simultaneously. References and Resources Eliott JA,…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses complementary therapy. References and Resources Wheeler P, Hyland ME. Dispositional predictors of complementary medicine and vitamin…
